AcuCort AB (ACUC) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to Investor Update. Today we have the Q1 report from AccuCort, which will be presented by AccuCort's CEO Jonas Jönmark via link. But as always, when we broadcast live, you can ask questions to the management, and you do that in the chat field. We will handle the questions after the presentation. With that said, it's high time to welcome Jonas Jönmark, CEO of AccuCort. Hello, Jonas. How are you? Hey. It's great here. It's full speed on all the cylinders. Yes, I understand. As I said, it was a quarter as hectic as the year ended. So with that said, here you go. Let's go through your presentation. Thank you very much. And welcome, everyone, who takes the time to watch this presentation. We are in a very intensive period of expansion after the very successful new emissions we did here at the beginning of the year. We are quickly entering the first quarter. As you have seen, no change has happened during the period. However, we have received an order for the Danish market from our commercial partners. And our team is preparing an order that is coming for the rest of the Nordic countries. The result after the tax went up to minus 6.5 million kronor, or yes, 6.5 million kronor, which was planned. And the result per share before and after the expansion went up to minus 0.04. In the cash box at the beginning of the period, there was about 38 million kronor. And important events during and after the quarter. Yes, you have seen that our pre-emission was recorded at 160%. And we went against the current, against many other biotech companies who tried to do the same thing during the same period. And that added about 48 million kronor to our emissions costs. So we have a stable economic foundation to take us forward in the company. We can also prove that we have ...